GlassScriptPhysician profile
Rajesh Kabra
NPI 1144231820
$42,401.95
in general payments reported to CMS, 2019-2025
34 companies · $9,107 in 2025
The $9,107 reported for 2025 was more than what 79% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $3,707 · 2021: $343 · 2022: $4,561 · 2023: $6,129 · 2024: $4,502 · 2025: $9,107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,609 · Food and Beverage: $7,162 · Travel and Lodging: $4,966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,609.47 |
| Food and Beverage | $7,162.12 |
| Travel and Lodging | $4,966.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $27,846.53 | 2019-2025 | Tacticath Ablation Catheter, Sensor Enabled, Aveir, Amplatzer Amulet |
| Medical Device Business Services, INC. | $3,225.26 | 2019-2024 | Carto 3 |
| Volta Medical INC | $3,090.16 | 2022-2024 | Vx1 |
| Medtronic, INC. | $2,268.00 | 2022-2025 | Micra, Linq II, Pulseselect |
| Altathera Pharmaceuticals LLC | $1,733.04 | 2025 | Sotalol Hydrochloride |
| Biosense Webster, INC. | $1,260.92 | 2019-2025 | Carto 3, Qdot Micro |
| Boston Scientific Corporation | $787.35 | 2019-2025 | Watchman Flx, Accolade Sr, Watchman Access System |
| Acutus Medical, INC. | $394.90 | 2022-2023 | |
| Atricure, INC. | $316.19 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $264.73 | 2022-2025 | Lifevest |
| Cardiva Medical, INC. | $162.67 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Bardy Diagnostics, INC. | $137.00 | 2021-2022 | |
| Novo Nordisk INC | $130.70 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $85.56 | 2022-2025 | Eliquis, Camzyos |
| Cordis US Corp. | $82.15 | 2025 | Mynx Control Venous |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $77.76 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.40 | 2022-2024 | Jardiance |
| Impulse Dynamics (USA) INC. | $69.78 | 2022-2023 | Optimizer |
| Novartis Pharmaceuticals Corporation | $57.55 | 2022-2025 | |
| Philips North America LLC | $49.39 | 2022-2024 | (5091) Amb Mon & Diag Und |
| Irhythm Technologies, INC. | $44.47 | 2023-2024 | Zio Xt Patch |
| Sanofi-Aventis U.S. LLC | $32.64 | 2022-2023 | |
| Recor Medical INC | $29.38 | 2025 | Paradise Ultrasound Renal Denervation System |
| Medtronic Vascular, INC. | $23.66 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.88 | 2022 | |
| Vital Connect, INC | $21.17 | 2024 | Vitalpatch Rtm |
| Kestra Medical Technology Services, INC. | $20.95 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $16.86 | 2024 | Arcalyst |
| Catheter Precision INC. | $15.62 | 2025 | |
| Janssen Pharmaceuticals, INC | $14.45 | 2024 | Xarelto |
| Baxter Healthcare | $14.44 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Glaxosmithkline, LLC. | $14.29 | 2025 | Shingrix |
| Astrazeneca Pharmaceuticals LP | $13.67 | 2025 | |
| Flowphysix INC | $7.43 | 2025 | Flowrunner |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajesh Kabra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.